Treatment of retinal pigment epithelial detachment with antiangiogenic therapy
Luis AriasDepartment of Ophthalmology, Bellvitge University Hospital, Barcelona, SpainPurpose: Evaluate the efficacy of pegaptanib, a selective anti-vascular endothelial growth factor (VEGF) agent, and bevacizumab, a nonselective anti-VEGF agent, for retinal pigment epithelial detachment (PED) assoc...
Main Author: | Luis Arias |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-04-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/treatment-of-retinal-pigment-epithelial-detachment-with-antiangiogenic-a4262 |
Similar Items
-
Serous retinal detachment and multiple retinal pigment epithelial detachments, following hemodialysis for multi-organ failure
by: Basu Soumyava, et al.
Published: (2010-01-01) -
Retinal Pigment Epithelial Detachment in Age-Related Macular Degeneration
by: Michael Karampelas, et al.
Published: (2020-08-01) -
Surgical treatment for neovascularized retinal pigment epithelial detachment in age-related macular degeneration
by: Hui Li
Published: (2013-02-01) -
Efficacy of reduced-fluence photodynamic therapy for serous retinal pigment epithelial detachment with choroidal hyperpermeability
by: Shibata A, et al.
Published: (2013-10-01) -
Evaluation of retinal pigment epithelium changes in serous pigment epithelial detachment in age-related macular degeneration
by: Masahiro Miura, et al.
Published: (2021-02-01)